Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5955)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Apr 21, 2023 (publication date) through Jun 4, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Bhatt A, Wu J. Immunotherapy for recurrent hepatocellular carcinoma. World J Gastroenterol 2023; 29(15): 2261-2271 [PMID: 37124885 DOI: 10.3748/wjg.v29.i15.2261] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v29/i15/2261.htm |
| Number | Citing Articles |
| 1 |
Boping Li, Shuang Wang, Baihui Shan, Baizhi Li, Fuqiu Li. A PD-L1xCD3 bispecific nanobody as a novel T-cell engager in treating PD-L1 overexpression melanoma. Molecular Immunology 2023; 163: 20 doi: 10.1016/j.molimm.2023.09.005
|
| 2 |
Grigorios Papadopoulos, Eirini Giannousi, Aikaterini P. Avdi, Rallia-Iliana Velliou, Polyxeni Nikolakopoulou, Antonios Chatzigeorgiou. Τ cell-mediated adaptive immunity in the transition from metabolic dysfunction-associated steatohepatitis to hepatocellular carcinoma. Frontiers in Cell and Developmental Biology 2024; 12 doi: 10.3389/fcell.2024.1343806
|
| 3 |
Junning Liu, Guangnian Zhang, Linfeng Yang, Duan Yan, Jiahui Yu, Song Wei, Jijiang Li, Pengsheng Yi. Salvage liver transplantation versus curative treatment for patients with recurrent hepatocellular carcinoma: A systematic review and meta-analysis. European Journal of Surgical Oncology 2024; 50(7): 108427 doi: 10.1016/j.ejso.2024.108427
|
| 4 |
Lixia Ma, Yu Zhang, Yong Fang, Chunyi Hao, Qingxia Fan, Da Jiang, Liqin Lu, Fang Su, Chen Yang, Zhenru Liu, Ji Tian, Xiyang Sun, Shuguang Sun, Ying Cheng. Anti-PD-L1 envafolimab combined with anti-VEGF suvemcitug in pretreated solid tumors and hepatocellular carcinoma: an open-label phase II study with safety run-in stage. Investigational New Drugs 2025; 43(2): 181 doi: 10.1007/s10637-025-01506-x
|
| 5 |
Wei Deng, Jin Xie, Tao Wang, Laihui Luo, Guoqing Zhu, Yongqiang Xiao, Jiahao Tao, Liucong Lin, Xian Ge, Wu Wen, Minglong Wang, Bin Yu, Yu Liu, Rongguang Luo, Renhua Wan, Zhigao Hu, Renfeng Shan. The safety and efficacy of tyrosine kinase inhibitors and programmed cell death protein- 1 inhibitors combined with HAIC/TACE in the treatment of recurrent unresectable hepatocellular carcinoma. BMC Cancer 2025; 25(1) doi: 10.1186/s12885-025-14185-x
|
| 6 |
Xianling Wang, Yan Yang, Shuang Zhao, Di Wu, Le Li, Zhifeng Zhao. Chitosan-based biomaterial delivery strategies for hepatocellular carcinoma. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1446030
|
| 7 |
Yusra Zarlashat, Shakil Abbas, Abdul Ghaffar. Hepatocellular Carcinoma: Beyond the Border of Advanced Stage Therapy. Cancers 2024; 16(11): 2034 doi: 10.3390/cancers16112034
|
| 8 |
Jin-You Guo, Li-Li Zhao, Hui-Jun Cai, Hui Zeng, Wei-Dong Mei. Radiofrequency ablation combined with transcatheter arterial chemoembolization for recurrent liver cancer. World Journal of Gastrointestinal Surgery 2024; 16(6): 1756-1764 doi: 10.4240/wjgs.v16.i6.1756
|
| 9 |
Huanling Guo, Guangliang Huang, Haiyi Long, Wenxin Wu, Ke Lin, Bin Qiao, Nan Zhang, Tongyi Huang, Yang Tan, Qi Zhang, Minru Zhang, Xiaoyan Xie, Xintao Shuai, Ming Xu, Chunyang Zhang. Harnessing PD-1-overexpressing macrophage membrane for preparation of lenvatinib-loaded vesicles to boost immunotherapy against HCC recurrence after radiofrequency ablation. Biomaterials 2025; 323: 123433 doi: 10.1016/j.biomaterials.2025.123433
|
| 10 |
Yu-Tang Chen, Bo-Wen-Tao Chen, Jun-Ming Xu, Xiao-Cui You, Yi Tang, Shao-Jie Wu, Zhu-Ting Fang. Multicenter Study on Transarterial Chemoembolization Combined with Radiofrequency Ablation for Early-Stage Hepatocellular Carcinoma: Primary versus Recurrent HCC. Journal of Hepatocellular Carcinoma 2024; : 2441 doi: 10.2147/JHC.S497956
|